×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
INSTITUTE OF APP... [2]
Faculty of Healt... [2]
Institute of Chi... [1]
THE STATE KEY LA... [1]
Authors
BIAN YING [1]
Document Type
Journal article [4]
Date Issued
2024 [1]
2023 [3]
Language
英語English [4]
Source Publication
Chemical Enginee... [2]
Medicine [1]
Nature Communica... [1]
Indexed By
SCIE [4]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-4 of 4
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA
Journal article
Zhang, Mengjie, Hussain, Abid, Hu, Bo, Yang, Haiyin, Li, Chunhui, Guo, Shuai, Han, Xiaofeng, Li, Bei, Dai, Yunlu, Cao, Yuhong, Chi, Hang, Weng, Yuhua, Qin, Cheng Feng, Huang, Yuanyu. Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA[J]. Nature Communications, 2024, 15(1), 6463.
Authors:
Zhang, Mengjie
;
Hussain, Abid
;
Hu, Bo
;
Yang, Haiyin
;
Li, Chunhui
; et al.
Favorite
|
TC[WOS]:
1
TC[Scopus]:
1
IF:
14.7
/
16.1
|
Submit date:2024/09/03
Serum Uric-acid
Urate Oxidase
Delivery
Sirna
Risk
Endocytosis
Therapy
An acid-engineered sericin nanoplatform enhances photothermal conversion and chemotherapy outcome for inducing immunogenic cell death
Journal article
Li, Xinyi, Ye, Mengjie, Huang, Renzhi, Hou, Shengxin, Xu, Jiming, Qiu, Wei, Liang, Mengyun, Gao, Yuan, Zhang, Hengbo, Xue, Peng, Kang, Yuejun, Shi, Xiaoxiao, Xu, Zhigang. An acid-engineered sericin nanoplatform enhances photothermal conversion and chemotherapy outcome for inducing immunogenic cell death[J]. Chemical Engineering Journal, 2023, 477, 146938.
Authors:
Li, Xinyi
;
Ye, Mengjie
;
Huang, Renzhi
;
Hou, Shengxin
;
Xu, Jiming
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
4
IF:
13.3
/
13.2
|
Submit date:2024/01/02
Chemo-photothermal Therapy
Immunogenic Cell Death
Natural Sericin
Ph-responsive
Photothermal Therapy
Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis
Journal article
Ge, Pu, Han, Chunyan, Reyila, Abudurousuli, Liu, Diyue, Hong, Wenying, Liu, Jiaxin, Zhang, Jinzi, Han, Xiao, Li, Xialei, Huang, Mengjie, Fan, Siyuan, Kaierdebieke, Ayidana, Wu, Xiaoyu, Huang, Xiaolu, Guo, Weirui, Liu, Siyu, Bian, Ying. Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis[J]. Medicine, 2023, 102(35), e34793.
Authors:
Ge, Pu
;
Han, Chunyan
;
Reyila, Abudurousuli
;
Liu, Diyue
;
Hong, Wenying
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
1.3
/
1.6
|
Submit date:2023/09/12
Adverse Events
Aflibercept
Antiangiogenesis
Meta-analysis
Metastatic Colorectal Cancer
Safety
Systematic Review
Engineering nanofusiform Iron-doped polydiaminopyridine boost intratumoral penetration for immunogenic cell Death-mediated synergistic Photothermal/Chemo therapy
Journal article
Zhang, Xiaoli, Hou, Shengxin, Liang, Mengyun, Xu, Jiming, Ye, Mengjie, Wang, Yuxin, Wen, Feiqiu, Xu, Zhigang, Liu, Sixi. Engineering nanofusiform Iron-doped polydiaminopyridine boost intratumoral penetration for immunogenic cell Death-mediated synergistic Photothermal/Chemo therapy[J]. Chemical Engineering Journal, 2023, 462, 142159.
Authors:
Zhang, Xiaoli
;
Hou, Shengxin
;
Liang, Mengyun
;
Xu, Jiming
;
Ye, Mengjie
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
6
IF:
13.3
/
13.2
|
Submit date:2023/05/02
Chemotherapy
Combined Therapy
Immunogenic Cell Death
Light Responsive
Photothermal Therapy